Bipartisan Bill Would Favor American-Made Drugs In Medicare, Medicaid

By John Wilkerson / April 5, 2022 at 3:39 PM

Bipartisan, bicameral legislation introduced Tuesday (April 5) would test a pay model that gives American-made medicines preferential treatment in Medicare, Medicaid and the Children’s Health Insurance Program.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.